Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

Patient Satisfaction Clinical Trial

Official title:

Evaluation of Providing Coffee to Patients Postoperatively to Decrease Length of Stay in the PACU

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03712891
• Other study ID #: 18-050
• Status: Active, not recruiting
• Phase: N/A
• Start date: October 25, 2018
• Est. completion date: October 2023

Study information

• Verified date: July 2023
• Source: TriHealth Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to determine if providing coffee to patients who self-identify as coffee drinkers postoperatively will decrease the length of stay in the post-anesthesia care unit (PACU).

Description:

Decreasing the length of stay in PACU for surgical patient is a pertinent outcome. The shorter length of stay can achieve higher patient engagement scores, while simultaneously increasing the productivity of the unit. This is achieved by making more beds available for new patients coming from the operating room (OR). One thought was that coffee would benefit the investigator's patients experience through a number of pathways. Initially, the stimulant effect of coffee would create a more alert patient. A more alert patient is more likely to comprehend home care instruction and be ready for discharge earlier. Coffee is often used as a remedy for morning sickness. Ideally the act of drinking coffee or even smelling the coffee may decrease the occurrence of Post-Operative Nausea and Vomiting (PONV) in investigator's patient population. Finally, patients frequently state that the inability to drink their morning coffee is often more difficult than not being able to eat prior to surgery. By allowing those to drink coffee in PACU this would make the patient feel that they are being cared for on an emotional level, in addition to a physical level.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 168
• Est. completion date: October 2023
• Est. primary completion date: July 1, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion criteria:

1. 18 years old or older

2. Admitted to Bethesda North Minimally Invasive Surgery Center

3. Reports to consume at least one cup of coffee a day for at least 5 days in a week

Exclusion Criteria

1. History of PONV

2. Pre-existing cardiac arrhythmias

3. History of seizure disorder

4. Pregnant

Related Conditions & MeSH terms

• PACU Length of Stay
• Patient Satisfaction
• Postoperative Nausea
• Postoperative Nausea and Vomiting
• Postoperative Vomiting
• Vomiting

Intervention

Dietary Supplement:
• Coffee
Patients will receive coffee in a Styrofoam cup at a temperature of 125 degree Fahrenheit or less. Coffee will be offered to the patient in the PACU once the patient's gag reflex has been restored following their procedure. Volume of estimated coffee consumption will be measured using a sample scale (with a maximum of 300mL of coffee offered)

Locations

Country	Name	City	State
United States	Bethesda North Hospital	Cincinnati	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
TriHealth Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PACU length of stay	Post-anesthesia Care Unit length of stay	6 hours